After COVID, a Continued Push for Diversity in Clinical Trials

The recent race to create a vaccine that could protect millions of people from a potentially deadly viral illness put a spotlight on an area in health care that’s long drawn concern, with companies emphasizing their pursuit of diversity in clinical trials for a COVID-19 shot. Three years later –